Related references
Note: Only part of the references are listed.The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
Yumie Takeshita et al.
DIABETOLOGIA (2014)
2013 ACC/AHA Guideline Recommends Fixed-Dose Strategies Instead of Targeted Goals to Lower Blood Cholesterol
Sidney C. Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice
Deborah Heydet et al.
DEVELOPMENTAL NEUROBIOLOGY (2013)
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
Christopher Savard et al.
HEPATOLOGY (2013)
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
Derrick M. Van Rooyen et al.
JOURNAL OF HEPATOLOGY (2013)
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
George N. Ioannou et al.
JOURNAL OF LIPID RESEARCH (2013)
Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat
Jeannie Chan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease
Veerle Bieghs et al.
PLOS ONE (2012)
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
Temitope Foster et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Melanocortin 4 Receptor-Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis
Michiko Itoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
Derrick M. van Rooyen et al.
GASTROENTEROLOGY (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
Savitha Subramanian et al.
JOURNAL OF LIPID RESEARCH (2011)
Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver
Michal Ganz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Dick C. Chan et al.
DIABETES CARE (2010)
NPC1L1 and cholesterol transport
Jenna L. Betters et al.
FEBS LETTERS (2010)
Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice
Kristiaan Wouters et al.
FEBS LETTERS (2010)
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
Masato Yoneda et al.
HEPATOLOGY RESEARCH (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation
Kristiina Rajamaki et al.
PLOS ONE (2010)
Association Between Dietary Nutrient Composition and the Incidence of Cirrhosis or Liver Cancer in the United States Population
George N. Ioannou et al.
HEPATOLOGY (2009)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Esterified Cholesterol Is Highly Localized to Bruch's Membrane, as Revealed by Lipid Histochemistry in Wholemounts of Human Choroid
Martin Rudolf et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Shuqin Zheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
Kristiaan Wouters et al.
HEPATOLOGY (2008)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Veit Hornung et al.
NATURE IMMUNOLOGY (2008)
The Nalp3 inflammasome is essential for the development of silicosis
Suzanne L. Cassel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica
Catherine Dostert et al.
SCIENCE (2008)
Adipocyte death, adipose tissue remodeling, and obesity complications
Katherine J. Strissel et al.
DIABETES (2007)
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Naoto Matsuzawa et al.
HEPATOLOGY (2007)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
In vivo responsiveness to ezetimibe correlates with Niemann-Pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs
Brian E. Hawes et al.
MOLECULAR PHARMACOLOGY (2007)
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
Vasilios G. Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
S Cinti et al.
JOURNAL OF LIPID RESEARCH (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
I Tabas
JOURNAL OF CLINICAL INVESTIGATION (2002)
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
E Bugianesi et al.
GASTROENTEROLOGY (2002)
Share Paper
